These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22894162)

  • 21. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M; Lacy B
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of semi-automated metabolite identification software in the drug discovery process for rapid identification of metabolites and the cytochrome P450 enzymes responsible for their formation.
    Ramanathan R; McKenzie DL; Tugnait M; Siebenaler K
    J Pharm Biomed Anal; 2002 Jun; 28(5):945-51. PubMed ID: 12039637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico prediction of cytochrome P450-mediated site of metabolism (SOM).
    Liu X; Shen Q; Li J; Li S; Luo C; Zhu W; Luo X; Zheng M; Jiang H
    Protein Pept Lett; 2013 Mar; 20(3):279-89. PubMed ID: 22591483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
    Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of in silico contributions to drug metabolism in lead optimization.
    Vaz RJ; Zamora I; Li Y; Reiling S; Shen J; Cruciani G
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):851-61. PubMed ID: 20565339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.
    Yao ZJ; Dong J; Che YJ; Zhu MF; Wen M; Wang NN; Wang S; Lu AP; Cao DS
    J Comput Aided Mol Des; 2016 May; 30(5):413-24. PubMed ID: 27167132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative structure-metabolism relationship modeling of metabolic N-dealkylation reaction rates.
    Balakin KV; Ekins S; Bugrim A; Ivanenkov YA; Korolev D; Nikolsky YV; Ivashchenko AA; Savchuk NP; Nikolskaya T
    Drug Metab Dispos; 2004 Oct; 32(10):1111-20. PubMed ID: 15269187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico methods for predicting ligand binding determinants of cytochromes P450.
    de Groot MJ; Kirton SB; Sutcliffe MJ
    Curr Top Med Chem; 2004; 4(16):1803-24. PubMed ID: 15579109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based methods for the prediction of the dominant P450 enzyme in human drug biotransformation: consideration of CYP3A4, CYP2C9, CYP2D6.
    Manga N; Duffy JC; Rowe PH; Cronin MT
    SAR QSAR Environ Res; 2005; 16(1-2):43-61. PubMed ID: 15844442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources.
    Liu Z; Guo F; Gu J; Wang Y; Li Y; Wang D; Lu L; Li D; He F
    Bioinformatics; 2015 Jun; 31(11):1788-95. PubMed ID: 25638810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.
    Orhan H; Vermeulen NP
    Curr Drug Metab; 2011 May; 12(4):383-94. PubMed ID: 21395525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R; Liu J; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.
    Cece-Esencan EN; Fontaine F; Plasencia G; Teppner M; Brink A; Pähler A; Zamora I
    Rapid Commun Mass Spectrom; 2016 Jan; 30(2):301-10. PubMed ID: 26689160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
    Carosati E
    Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
    He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules.
    Singh SB; Shen LQ; Walker MJ; Sheridan RP
    J Med Chem; 2003 Apr; 46(8):1330-6. PubMed ID: 12672233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.